Ryman Healthcare Limited
RHCGF
$1.44
$0.22518.60%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 105.29M | 109.55M | 104.80M | 103.71M | 102.24M |
| Total Other Revenue | 6.54M | 6.80M | 6.83M | 6.76M | 6.53M |
| Total Revenue | 111.83M | 116.35M | 111.63M | 110.47M | 108.78M |
| Cost of Revenue | 116.17M | 120.86M | 104.49M | 103.40M | 129.08M |
| Gross Profit | -4.34M | -4.51M | 7.14M | 7.06M | -20.30M |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | 6.54M | 6.81M | 7.77M | 7.68M | 7.43M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 122.71M | 127.67M | 112.25M | 111.09M | 136.51M |
| Operating Income | -10.88M | -11.32M | -629.10K | -622.60K | -27.73M |
| Income Before Tax | -110.75M | -115.22M | 53.44M | 52.88M | -124.20M |
| Income Tax Expenses | 40.02M | 41.64M | 24.59M | 24.33M | -14.95M |
| Earnings from Continuing Operations | -150.77M | -156.85M | 28.85M | 28.55M | -109.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -150.77M | -156.85M | 28.85M | 28.55M | -109.25M |
| EBIT | -10.88M | -11.32M | -629.10K | -622.60K | -27.73M |
| EBITDA | -7.82M | -8.14M | 6.78M | 6.70M | -24.42M |
| EPS Basic | -0.21 | -0.21 | 0.04 | 0.04 | -0.16 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.02 | -0.02 | -0.04 |
| EPS Diluted | -0.21 | -0.21 | 0.04 | 0.04 | -0.16 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.02 | -0.02 | -0.04 |
| Average Basic Shares Outstanding | 732.74M | 732.74M | 687.64M | 687.64M | 687.64M |
| Average Diluted Shares Outstanding | 732.74M | 732.74M | 687.64M | 687.64M | 687.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |